EZH2 and breast cancer: First, we found that knockdown of EZH2 by small interfering RNA (siRNA) did not influence the expression of TFIIIC components in neither of the two breast cancer cell lines MCF7 and SUM159 (Supplementary Figure S2a and b), indicating EZH2 could not regulate TFIIIC expression.